ArticleOTO open

Thyroid Cancer Risk in Patients With Type 2 Diabetes Taking Glucagon-Like Peptide 1 Receptor Agonists.

Bao Y Sciscent et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.